跳至主要内容
临床试验/CTRI/2014/02/004406
CTRI/2014/02/004406已完成1 期

Effects of novel polyherbal formulation on cytochrome P450 enzymes mediated drug metabolism

SRM University0 个研究点目标入组 12 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Healthy female volunteers of 18 to 45 years (both years inclusive).
  • 2. Willing to give informed written consent and comply with the study requirements.
  • 3. Subject should be able to communicate effectively.
  • 4. Non-smokers and Non-Alcoholic.
  • 5. Body Mass Index (BMI) between 18.50 and 24.99 Kg/m2.
  • 6. Healthy individuals as evaluated by personal history, medical history and general clinical examination.
  • 7. Vital parameters - BP should be within the range of 100 â?? 139 mmHg systolic and 60 â?? 89 mmHg diastolic. Pulse rate should be within the range of 60 â?? 100 / min. Oral temperature between 97.8 F and 99.0 F. Respiratory rate should be within the range of 14-18/min.
  • 8. Normal biochemical, hematological and urinary parameters.
  • 9. Normal Chest X - ray PA view & ECG in 12 leads
  • 10.Negative for HIV 1 & 2, Hepatitis B, Hepatitis C and Syphilis tests.

排除标准

  • 1. Subjects incapable of understanding the informed consent.
  • 2. History of any major surgical procedure in the past 3 months.
  • 3. History of diabetes mellitus, tuberculosis and systemic hypertension.
  • 4. Pregnant or lactating women.
  • 5. History suggestive of cardiac, gastrointestinal, respiratory, hepatic, renal, endocrine, neurological, metabolic, psychiatric or hematological systems, judged to be clinically significant.
  • 6. History of dysphagia.
  • 7. History of any medical disorder that is of significance in the investigatorâ??s opinion.
  • 8. Present or past history of drug abuse.
  • 9. History of hypersensitivity to study formulation.
  • 10. History of allergy to vegetables and / or food substances and / or any other manifestations suggestive of hypersensitivity reactions.
  • 11. Present or past history of intake of drugs which potentially modify kinetics / dynamics of study medication or any other medication judged to be clinically significant by the investigator.
  • 12. Consumption of grapefruit / its products within 48 hours prior to the start of study.
  • 13. Subject with clinically significant abnormal values of laboratory parameters.
  • 14. Subject who had participated in any other clinical study during the last 3 months.
  • 15. Subject who had bled in the past 3 months from the date of start of study either for blood donation or for any other reason.
  • 16. History of habituation to coffee, tea or other xanthine containing products and inability to withhold the intake during the - in house - stay

研究者

相似试验

Effects of polyherbal formulation on cytochrome P450... | 临床试验